|
Canada - XiteBio SoyRhizo XV receives registration from CFIA - An innovative soybean inoculant for tomorrow’s farmers
Winnipeg, Manitoba, Canada
February 19, 2026
XiteBio Technologies Inc. is pleased to announce the registration of XiteBio® SoyRhizo® XV inoculant from Canadian Food Inspection Agency (CFIA). XiteBio® SoyRhizo® XV is the only premium brand liquid soybean inoculant powered by XiteBio’s proprietary Advanced Growth Promoting Technology (AGPT®), featuring a highly concentrated formulation and lower seed-applied use rate. The new formulation is designed to integrate efficiently with other seed treatments, and it exceeds the markets current demand and beyond. The demand for maximizing on-seed treatment is at an all time high and XiteBio® SoyRhizo® XV will simplify that need with the lower use rate.
“The approval of XiteBio® SoyRhizo® XV marks an important milestone in our commitment to innovation for the growers of North America,” says Dr. Manas Banerjee, CEO of XiteBio Technologies Inc. “By delivering a concentrated formulation with a reduced use rate, we’re providing greater flexibility without compromising performance that accommodates other necessary seed treatment options”.
“We’re excited to officially launch XiteBio® SoyRhizo® XV for the 2026 Canadian growing season,” says Eva Smuck, Eastern Canadian Sales Manager at XiteBio. “This new concentrated formulation delivers the same trusted performance growers expect, like 120 days on seed, and is based on our proprietary AGPT® while offering greater efficiency on seed.” While new to Canada in 2026, XiteBio® SoyRhizo® XV was successfully introduced in the U.S. in 2025. “XiteBio® SoyRhizo® XV rapidly gained acceptance following its 2025 U.S. launch,” says Doug Tigges, XiteBio’s US Sales Manager. “Customers value its quality, ease of use, and reduced application rate to maximize on-seed treatment potential,” Tigges added.
XiteBio® SoyRhizo® XV’s unique formulation not only meets the current market demand but goes beyond to meet the needs of tomorrow’s grower. The reduced seed-applied rate allows users to maximize the availability of space on-seed without sacrificing inoculant quality. Nodulation for soybeans is necessary and XiteBio® SoyRhizo® XV is a perfect solution that can work with seed treatments and fertilizers.
XiteBio Technologies Inc. is a privately owned Canadian ag-biotech company. XiteBio’s head office and IRD Centre is located in Winnipeg, Canada. XiteBio researches, develops and markets innovative & value-added inoculants & ag-biological products for today’s and tomorrow’s farmers. XiteBio’s products in North American market includes: SoyRhizo® for soybean, and PulseRhizo® for pea, lentil & faba bean, are premium inoculants powered by AGPT® (Advanced Growth Promoting Technology). XiteBio® Yield+ line of products (namely XiteBio® Yield+, XiteBio® Tuber+, XiteBio® Vegi+) are available for oilseeds, cereals, legumes, tuber & vegetable crops, and feature patented phosphate-solubilizing PGPR technology. The unique dual inoculant XiteBio® OptiPlus® is also available as in-furrow application for soybeans throughout North America.
More news from: Xitebio Technologies Inc.
Website: http://www.xitebio.ca Published: February 20, 2026 |
|
The news item on this page is copyright by the organization where it originated Fair use notice |